ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC)
Authors
Lawless, CHatton, M
Faivre-Finn, Corinne
Landau, D
Boyd, K
Fenwick, J
Lester, J
Mccartney, E
Paul, J
Shaw, A
Simoes, R
Affiliation
College of Medical, Veterinary and Life Sciences, CRUK Clinical Trials Unit, Glasgow/GBIssue Date
2018
Metadata
Show full item recordCitation
Lawless C, Hatton M, Faivre-Finn C, Landau D, Boyd K, Fenwick J, et al. P2.01-43 ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S681.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2018.08.1097Additional Links
https://dx.doi.org/10.1016/j.jtho.2018.08.1097Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2018.08.1097